Paul Prefontaine

Quebec, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-β Pathology in APP/PS1 Mice.

Herpes Simplex Virus 1 Infection Does Not Increase Amyloid-β Pathology in APP/PS1 Mice.

Journal: Journal of Alzheimer's disease : JAD

Published: December 25, 2023

Muramyl Dipeptide Administration Delays Alzheimer's Disease Physiopathology via NOD2 Receptors.

Muramyl Dipeptide Administration Delays Alzheimer's Disease Physiopathology via NOD2 Receptors.

Journal: Cells

Published: June 02, 2022

Correction to: Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis.

Correction to: Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: April 28, 2021

Early monocyte modulation by the non-erythropoietic peptide ARA 290 decelerates AD-like pathology progression.

Early monocyte modulation by the non-erythropoietic peptide ARA 290 decelerates AD-like pathology progression.

Journal: Brain, behavior, and immunity

Published: March 30, 2021

Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis.

Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: December 18, 2020

Muramyl dipeptide-mediated immunomodulation on monocyte subsets exerts therapeutic effects in a mouse model of Alzheimer's disease.

Muramyl dipeptide-mediated immunomodulation on monocyte subsets exerts therapeutic effects in a mouse model of Alzheimer's disease.

Journal: Journal of neuroinflammation

Published: February 26, 2020

Role of Macrophage Colony-Stimulating Factor Receptor on the Proliferation and Survival of Microglia Following Systemic Nerve and Cuprizone-Induced Injuries.

Role of Macrophage Colony-Stimulating Factor Receptor on the Proliferation and Survival of Microglia Following Systemic Nerve and Cuprizone-Induced Injuries.

Journal: Frontiers in immunology

Published: November 04, 2019

Bone Marrow Chimeras to Study Neuroinflammation.

Bone Marrow Chimeras to Study Neuroinflammation.

Journal: Current protocols in immunology

Published: September 18, 2018

mCSF-Induced Microglial Activation Prevents Myelin Loss and Promotes Its Repair in a Mouse Model of Multiple Sclerosis.

mCSF-Induced Microglial Activation Prevents Myelin Loss and Promotes Its Repair in a Mouse Model of Multiple Sclerosis.

Journal: Frontiers in cellular neuroscience

Published: April 25, 2018

Role of the chemokine receptors CCR2 and CX3CR1 in an experimental model of thrombotic stroke.

Role of the chemokine receptors CCR2 and CX3CR1 in an experimental model of thrombotic stroke.

Journal: Brain, behavior, and immunity

Published: October 19, 2017

Triggering of NOD2 Receptor Converts Inflammatory Ly6Chigh into Ly6Clow Monocytes with Patrolling Properties.

Triggering of NOD2 Receptor Converts Inflammatory Ly6Chigh into Ly6Clow Monocytes with Patrolling Properties.

Journal: Cell reports

Published: February 14, 2017

Inefficient clearance of myelin debris by microglia impairs remyelinating processes.

Inefficient clearance of myelin debris by microglia impairs remyelinating processes.

Journal: The Journal of experimental medicine

Published: August 26, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026